• ABPI Website
  • Media
  • ABPI response to launch of UK and Switzerland free trade agreement negotiations 

ABPI response to launch of UK and Switzerland free trade agreement negotiations 

The Government has announced the launch of negotiations for an updated free trade agreement with Switzerland. 

Claire Machin, Executive Director, International Policy, Association of the British Pharmaceutical Industry, said:

“Negotiation of an Enhanced Trade Agreement between the UK and Switzerland provides a pivotal opportunity for a world-leading agreement between two life science superpowers.  

 

“Prioritisation of life sciences in negotiations could help to boost the growth of our two innovation-intensive economies and set world-leading standards to encourage the creation and adoption of the next wave of scientific technologies.” 

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.